The Effectiveness of Articaine in Brachial Plexus Blockade: A Prospective Randomized Trial
- Authors: Lakhin R.Е.1,2, Tsvetkov V.G.1, Polezhankin E.V.1, Zhirnova E.A.3, Babicheva P.A.1, Kuchina S.N.1
-
Affiliations:
- Kirov Military Medical Academy, Saint Petersburg, Russia
- Saratov State Medical University named after V.I. Razumovsky, Saratov, Russia
- Saint-Petersburg State University, Saint Petersburg, Russia
- Section: Original study articles
- Submitted: 08.12.2024
- Accepted: 16.06.2025
- Published: 16.06.2025
- URL: https://rjraap.com/1993-6508/article/view/642696
- DOI: https://doi.org/10.17816/RA642696
- ID: 642696
Cite item
Abstract
BACKGROUND: Articaine has become widely used for infiltration and conduction anesthesia in dentistry, but there are still few studies on its use for regional blockades during limb surgery.
AIM: To assess the development and duration of sensory and motor blockade during regional anesthesia with articaine compared with ropivacaine during operations on the upper limb.
METHODS: A single-center prospective randomized trial was conducted. 60 patients operated on the upper extremities under regional anesthesia were included. The patients were randomized into groups: Group 1 (n=30) with the use of 2% articaine solution for blockade, Group 2 (n=30) — 0.5% ropivacaine solution. The groups were divided into subgroups (n=15) depending on the blockade of the interlobular or axillary access. The primary point of the study was the assessment of the development of sensory and motor blocks. The secondary points were the duration of the blockade, the frequency of side effects (nausea/vomiting, hypotension, bradycardia, dizziness).
RESULTS: When examining the characteristics of sensory blockade 30 minutes after administration of the anesthetic, statistical differences were found only in the rate of development of the blockade. The use of articaine led to a more rapid development of the sensory block in both the intercellular [in Group 1 7.0±2.9 min, in Group 2 10.0±3.1 min (p=0.015)] and axillary blockade [in Group 1 8.0±2.1 min, in Group 2 12.0±4.2 min (p=0.02)]. In case of interlateral blockade, the absence of movement in the shoulder area was achieved in 12 (80%) patients of group 1, and in 13 (86.7%) of group 2. With axillary block, flexion in the fingers was absent in 8 (53.3%) in group 1 and in 9 (60%) patients in group 2 (p=0.117). The duration of sensory blockade (12.1±5.4 hours vs. 3.1±0.5 hours, p=0.001), motor blockade (5.3±2.2 hours vs. 2.2±0.8 hours, p=0.016) by interlobular access and sensory blockade (10.3±3.2 hours vs. 2.8±0.7 hours, p=0.001), motor blockade blockade (4.9±1.4 hours vs. 1.7±0.4 hours, p=0.02) by axillary access was greater in patients in the ropivacaine group than in the articaine group. According to the frequency of complications, hoarseness of the voice was more common with ropivacaine blockade (p=0.03).
CONCLUSION: The quality and severity of the blockade of the peripheral nerves of the brachial plexus when using articaine is not inferior to the blockade using ropivacaine. Articaine blockade differs from ropivacaine blockade by a higher rate of sensory anesthesia and a shorter duration of sensory and motor blocks. According to the frequency of complications in the articaine group, the occurrence of hoarseness of the voice was less frequent.
Keywords
Full Text

About the authors
Roman Е. Lakhin
Kirov Military Medical Academy, Saint Petersburg, Russia; Saratov State Medical University named after V.I. Razumovsky, Saratov, Russia
Email: doctor-lahin@yandex.ru
ORCID iD: 0000-0001-6819-9691
SPIN-code: 7261-9985
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Saint Petersburg, Russia; Saratov, RussiaVasily G. Tsvetkov
Kirov Military Medical Academy, Saint Petersburg, Russia
Email: vasilii_cvetkov@mail.ru
ORCID iD: 0000-0003-4980-597X
SPIN-code: 5316-4617
Russian Federation, Saint Petersburg, Russia
Evgeniy V. Polezhankin
Kirov Military Medical Academy, Saint Petersburg, Russia
Email: vasilii_cvetkov@mail.ru
ORCID iD: 0009-0007-6311-1698
Russian Federation, Saint Petersburg, Russia
Ekaterina A. Zhirnova
Saint-Petersburg State University, Saint Petersburg, Russia
Email: kate-embrace@mail.ru
ORCID iD: 0000-0003-1865-3838
SPIN-code: 1018-3223
anesthesiologists, resuscitators
Russian Federation, Saint Petersburg, RussiaPolina A. Babicheva
Kirov Military Medical Academy, Saint Petersburg, Russia
Email: polisish30@gmail.com
ORCID iD: 0009-0003-7454-1993
Russian Federation, Saint Petersburg, Russia
Svetlana N. Kuchina
Kirov Military Medical Academy, Saint Petersburg, Russia
Author for correspondence.
Email: svetl.kuchina@mail.ru
ORCID iD: 0000-0001-7893-3183
SPIN-code: 1860-5110
anesthesiologist-intensive care physician, postgraduate student
Russian Federation, Saint Petersburg, RussiaReferences
- Zhang H, Wu J, Miao Y, et al. Determination of the Optimal Volume of 0.5% Ropivacaine in Single-Injection Retroclavicular Brachial Plexus Block for Arthroscopic Shoulder Surgery: A Phase I/II Trial. Anesthesiology. 2025;142(1):155–165. doi: 10.1097/ALN.0000000000005159
- Xuan Q, Pan R, Wang A, et al. The 90% minimum effective volume of 0.5 ropivacaine for ultrasound-guided supraclavicular brachial plexus block : A biased coin up-and-down design. Anaesthesiologie. 2023;72(Suppl 1):39–43. doi: 10.1007/s00101-023-01344-7
- Wu L, Zhang W, Zhang X, et al. Optimal concentration of ropivacaine for brachial plexus blocks in adult patients undergoing upper limb surgeries: a systematic review and meta-analysis. Front Pharmacol. 2023;14:1288697. doi: 10.3389/FPHAR.2023.1288697
- Van Oss GE, Vree TB, Baars AM, et al. Pharmacokinetics, metabolism, and renal excretion of articaine and its metabolite articainic acid in patients after epidural administration. Eur J Anaesthesiol. 1989;6(1):49–56.
- Moller RA, Covino BG. Cardiac electrophysiologic effects of articaine compared with bupivacaine and lidocaine. Anesth Analg. 1993;76(6):1266–1273. doi: 10.1213/00000539-199306000-00014
- Simon MAM, Vree TB, Gielen MJM, et al. Similar motor block effects with different disposition kinetics between lidocaine and (+ or -) articaine in patients undergoing axillary brachial plexus block during day case surgery. Int J Clin Pharmacol Ther. 1999;37(12):598–607.
- Armanious SH, Abdelhameed GA. A Randomized Controlled Trial: Comparison of 4% Articaine versus 0.5% Bupivacaine for Ambulatory Orthopedic Surgery under Supraclavicular Block. Anesthesiol Res Pract. 2020;2020:2194873. doi: 10.1155/2020/2194873
- Ertikin A, Argun G, Mısırlıoğlu M, et al. Comparison Between the Two-Injection Technique and the Four-Injection Technique in Axillary Brachial Plexus Block with Articaine. Turk J Anaesthesiol Reanim. 2017;45(5):289–296. doi: 10.5152/TJAR.2017.16023
- Kilinc L, Cinar S, Turk HS. Prolonged Analgesic Efficacy of Articaine with the Addition of Tramadol in Axillary Brachial Plexus Block. Sisli Etfal Hastan Tip Bul. 2019;53(1):21–26. doi: 10.14744/SEMB.2018.03274
- Karelov AE, Vasilieva GN, Semkichev VA, et al. Articaine using for out-hospital patients with side effects to lidocaine: a pilot study. Russian Journal of Anesthesiology and Reanimatology. 2022;(2):41–46. doi: 10.17116/anaesthesiology202202141 EDN: ZIGMZH
- Bayalieva AZ, Yankovich YN, Mohsin M, Davydova VR. Possibilities of clinical application of articaine. Regional Anesthesia and Acute Pain Management. 2022;16(2):103–114. doi: 10.17816/RA108091 EDN: MOMOFN
- Krainyukov PE, Agafonov DE, Kokorin VV, et al. Influence of the choice of tactics of surgical treatment of victims with battle lesions of the lower limb on their psycho-emotional status. Bulletin of Pirogov National Medical & Surgical Center. 2023;18(4):98–102. doi: 10.25881/20728255_2023_18_4_98 EDN: CZOSCY
- Chulovskaya IG, Egiazaryan K, Shatov AM, Kosmynin VS. The use of articaine for anesthetic support in geriatric patients with degenerative-dystrophic hand and forearm conditions: results of a randomized trial. Surgical practice (Russia). 2023;(3): 59–72. doi: 10.38181/2223-2427-2023-3-5 EDN: HSENVI
- Lee R, Kim YM, Choi EM, et al. Effect of warmed ropivacaine solution on onset and duration of axillary block. Korean J Anesthesiol. 2012;62(1):52–56. doi: 10.4097/kjae.2012.62.1.52
- Vasavada K, Jahagirdar V, Rama K, Qavi D. Minimum Effective Volume of 0.75% Ropivacaine for Ultrasound-Guided Axillary Brachial Plexus Block. Cureus. 2020;12(12):e12229
- Yurtlu DA, Kaya K. Ropivacaine, articaine or combination of ropivacaine and articaine for epidural anesthesia in cesarean section: a randomized, prospective, double-blinded study. Braz J Anesthesiol. 2013;63(1):85–91. doi: 10.1016/j.bjane.2012.03.005
- Fanelli G, Casati A, Garancini P, et al. Nerve stimulator and multiple injection technique for upper and lower limb blockade: failure rate, patient acceptance, and neurologic complications. Study Group on Regional Anesthesia. Anesth Analg. 1999;88(4):847–852. doi: 10.1097/00000539-199904000-00031
- Vester‐Andersen T, Husum B, Lindeburg T, et al. Perivascular axillary block IV: blockade following 40, 50 or 60 ml of mepivacaine 1% with adrenaline. Acta Anaesthesiol Scand. 1984;28(1):99–105. doi: 10.1111/j.1399-6576.1984.tb02020.x
- Vadagandla K, Jahagirdar V, Rama K, et al. Minimum Effective Volume of 0.75% Ropivacaine for Ultrasound-Guided Axillary Brachial Plexus Block. Cureus. 2020;12(12):e12229. doi: 10.7759/CUREUS.12229
- Gautier P, Vandepitte C, Ramquet C, et al. The minimum effective anesthetic volume of 0.75% ropivacaine in ultrasound-guided interscalene brachial plexus block. Anesth Analg. 2011;113(4):951–955. doi: 10.1213/ANE.0b013e31822b876f
- Mittal K, Janweja S, Prateek P, et al. Mittal K, Janweja S, Prateek, Sangwan P, Agarwal D, Tak H. The estimation of minimum effective volume of 0.5% ropivacaine in ultrasound-guided interscalene brachial plexus nerve block: A clinical trial. J Anaesthesiol Clin Pharmacol. 2019;35(1):41–46. doi: 10.4103/joacp.JOACP_70_18
Supplementary files
